Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
PHASE2/PHASE3
120 participants
INTERVENTIONAL
2020-03-23
2020-12-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Multicenter Clinical Study on the Efficacy and Safety of Xiyanping Injection in the Treatment of New Coronavirus Infection Pneumonia (General and Severe)
NCT04295551
A Study of Neutrexin Plus Leucovorin in the Treatment of Pneumocystis Carinii Pneumonia (PCP)
NCT00002434
A Study to Evaluate the Safety and Effect of STC3141 Continuous Infusion in Subjects With Severe Corona Virus Disease 2019（COVID-19）Pneumonia
NCT04880694
The Clinical Study of Carrimycin on Treatment Patients With COVID-19
NCT04286503
Phase 1 Randomized Double-blind Placebo Controlled Study to Evaluate Safety and PK of MEDI3902 in Healthy Adults
NCT02255760
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NON_RANDOMIZED
PARALLEL
SUPPORTIVE_CARE
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
oral escin group
Standard therapy+Escin tablet 40mg\*3, os for 12 days
Escin
treatment with escin or escinate sodium
standard therapy
antiviral drugs
control group
standard therapy
standard therapy
antiviral drugs
parenteral escin group
standard treatment + sodium Escinate 20mg iv/day for 12 days
Escin
treatment with escin or escinate sodium
standard therapy
antiviral drugs
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Escin
treatment with escin or escinate sodium
standard therapy
antiviral drugs
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Positivity to covid-19 screening test in molecular biology
* In escin group: Low response to standard treatment
* Ability to understand and the willingness to sign a written informed consent document
Exclusion Criteria
* patients with previous history to allergy
* patients meet the contraindications of escin
* Patients have any condition that in the judgement of the Investigators would make the subject inappropriate for entry into this study.
* patients can't take drugs orally
18 Years
75 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Azienda Ospedaliera Pugliese Ciaccio
OTHER
Azienda Ospedaliera Universitaria Mater Domini, Catanzaro
OTHER
University of Catanzaro
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Luca Gallelli
Clinical Professor
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Luca Gallelli
Catanzaro, , Italy
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
covid-19 add-on therapy
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.